Hepatitis with fibrin-ring granulomas

Infection

Volumn 36, Issue 4, 2008, Pages 381-383

  Khanlari, B ^a   Bodmer, M ^a   Terracciano, L ^a   Heim, M H ^a   Fluckiger, U ^a   Weisser, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; LISINOPRIL; PREDNISONE; PROPRANOLOL; STEROID;

AGED; AMASTIGOTE; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; GOUT; GRANULOMATOUS HEPATITIS; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERTENSION; LABORATORY TEST; LEG EDEMA; LEISHMANIA INFANTUM; LEISHMANIASIS; LIVER BIOPSY; LIVER DISEASE; MULTIPLE ORGAN FAILURE; OBESITY; PANCYTOPENIA; PHYSICAL EXAMINATION; PNEUMONIA; SIDE EFFECT; SPLENOMEGALY;

AGED; ALLOPURINOL; ANIMALS; BIOPSY; BONE MARROW; FATAL OUTCOME; FEMALE; FIBRIN; GOUT SUPPRESSANTS; GRANULOMA; HEPATITIS, TOXIC; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LIVER;

EID: 50649104997     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-6365-8     Document Type: Article

References (17)

1. Marfurt J, Niederwieser I, Ntoh DM, Beck HP, Felger I: Diagnostic genotyping of old and new world leishmania species by PCR-RFLP. Diagn Microbiol Infect Dis 2003; 46: 115-124.
2. Marazuela M, Moreno A, Yebra M, Cerezo M, Gomez-Gesto M, Vargas JA: Hepatic fibrin-ring granulomas: a clinicopathologic study of 23 patients. Hum Pathol 1991; 22: 607-613.
3. Stricker BH, Blok AP, Babany G, Benhamou JP: Fibrin ring granulomas and allopurinol. Gastroenterology 1989; 96: 1199-1203.
4. le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, Rousseau D, Kubar J: Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 1999; 37: 1953-1957.
5. el Hag IA, Hashim FA, el Toum IA, Homeida M, el Kalifa M, el Hassan AM: Liver morphology and function in visceral leishmaniasis (Kala-azar). J Clin Pathol 1994; 47: 547-551.
6. Singh UK, Sinha RK, Sharma VK: Fulminant hepatitis in Kalaazar. Indian J Pediatr 1995; 62: 571-574.
7. Kumar PV, Omrani GH, Saberfirouzi M, et al. Kala-azar: liver fine needle aspiration findings in 23 cases presenting with a fever of unknown origin. Acta Cytol 1996; 40: 263-268.
8. Artan R, Yilmaz A, Akçam M, Aksoy NH: Liver biopsy in the diagnosis of visceral leishmaniasis. J Gastroenterol Hepatol 2006; 21: 299-302.
9. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD: Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.
10. Iraj Esfandiarpour MD, Afsáneh Alavi MD: Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. Int J Dermatol 2002; 41: 521-524.
11. Berman JD: Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies (review). Rev Infect Dis 1988; 10: 560-586.
12. Singh NK, Jha TK, Singh IJ, Jha S: Combination therapy in Kalaazar. J Assoc Physicians India 1995; 43: 319-320.
13. Llorente S, Gimeno L, Navarro MJ, Moreno S, Rodriguez M: Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials. Transplantation 2000; 70: 800-801.
14. Garcia-Cordoba F, et al. Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate. Ann Trop Med Parasitol 2005; 99: 125-130.
15. Scatena P: Visceral leishmaniasis in a patient treated for polyarteritis nodosa. Clin Exp Rheumatol 2003; 21: 121-123.
16. Malik A: Changing pattern of visceral Leishmaniasis, United Kingdom, 1985-2004. EID, 12: 1257-1259.
17. Badaro R: Leishmania donovani: an opportunistic microbe associated with progresssive disease in three immunocompromised patients. Lancet 1986; 647-649.